Clinical and echocardiographic findings in patients with COVID-19 across different severity levels
Cardiovascular pathology can complicate the course of COVID-19. The study aimed to identify echocardiographic abnormalities and key prognostic factors influencing severe and fatal COVID-19 outcomes. This retrospective cohort study included clinical and echocardiogram data from 194 medical records of...
Gespeichert in:
| Veröffentlicht in: | Journal of medicine and life 2023-11, Vol.16 (11), p.1692-1700 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1700 |
|---|---|
| container_issue | 11 |
| container_start_page | 1692 |
| container_title | Journal of medicine and life |
| container_volume | 16 |
| creator | Hryzhak, Ihor Pryshliak, Oleksandra Kobryn, Taras Fedorov, Sergiy Boichuk, Oleksandr Marynchak, Oleksandra Kvasniuk, Viktoriia Protsyk, Andrii Miziuk, Ruslan Kucher, Andrii Simchych, Marianna Hryzhak, Lilia Kuravkin, Mariia |
| description | Cardiovascular pathology can complicate the course of COVID-19. The study aimed to identify echocardiographic abnormalities and key prognostic factors influencing severe and fatal COVID-19 outcomes. This retrospective cohort study included clinical and echocardiogram data from 194 medical records of hospitalized patients with COVID-19: 100 moderate cases, 34 severe cases with favorable outcomes, and 60 severe cases with fatal outcomes. Severe patients with favorable outcomes had greater reductions in left ventricular systolic fraction of left ventricle compared to moderate cases (23.5%
. 7.0%, respectively, p=0.008) and ejection fraction of left ventricle (14.7%
. 3.0%, respectively, p=0.013), grade I diastolic dysfunction of the left ventricle (20.6%
. 8.0%, respectively, p=0.044), and pulmonary hypertension (29.41%
. 10.0%, respectively, p=0.006). Patients with fatal outcomes had a mean age of 67.1±1.51 years, chronic heart failure functional class II (58.3%), hypertension (50.0%), type 2 diabetes (43.3%), and obesity (33.3%). Compared to severe cases but with favorable outcomes, fatal cases had a greater decrease in left ventricular ejection fraction (36.7%
. 14.7%, respectively, p=0.024), various types of myocardial dysfunction (51.7%
. 29.4%, respectively, p=0.037) and a trend towards increased pulmonary hypertension (48.3%
. 29.4%, respectively, p=0.074). Consequently, chronic heart failure class II, reduced left ventricular ejection fraction, various myocardial dysfunctions, and pulmonary hypertension emerged as key cardiac risk factors for severe disease progression and mortality in patients with COVID-19. |
| doi_str_mv | 10.25122/jml-2023-0206 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10893567</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3054210736</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2896-89629cc62d93f59ec83f617ee49dfae7b3388bddd9214e17ec6b53a6e30f02793</originalsourceid><addsrcrecordid>eNpdUU1rGzEQFaElCWmuPQZBL71soo9daXUqxUkbQyCXtlehlUa2jKx1pbVD_n3kOAlpBYMG3pvHzHsIfabkknWUsavVOjaMMN4QRsQROqV92zacUvnhXX-CzktZkfraTgjBj9EJ71sipJSnaJjFkII1EZvkMNjlaE12YVxks1kGi31ILqRFwSHhjZkCpKnghzAt8ez-z_y6oQobm8dSsAveQ644LrCDHKZHHGsTyyf00ZtY4PzlP0O_f9z8mt02d_c_57Pvd41lvRJNLaasFcwp7jsFtudeUAnQKucNyIHzvh-cc4rRFipgxdBxI4ATT5hU_Ax9O-hutsManK2rZBP1Joe1yY96NEH_i6Sw1ItxpynpFe-ErApfXxTy-HcLZdLrUCzEaBKM26KZ4tXtaqmo1C__UVfjNqd6n-akaxklku9ZlwfWs0UZ_Ns2lOjnCHWNUO8j1PsI68DF-xve6K-B8ScZPJfW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3054210736</pqid></control><display><type>article</type><title>Clinical and echocardiographic findings in patients with COVID-19 across different severity levels</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Hryzhak, Ihor ; Pryshliak, Oleksandra ; Kobryn, Taras ; Fedorov, Sergiy ; Boichuk, Oleksandr ; Marynchak, Oleksandra ; Kvasniuk, Viktoriia ; Protsyk, Andrii ; Miziuk, Ruslan ; Kucher, Andrii ; Simchych, Marianna ; Hryzhak, Lilia ; Kuravkin, Mariia</creator><creatorcontrib>Hryzhak, Ihor ; Pryshliak, Oleksandra ; Kobryn, Taras ; Fedorov, Sergiy ; Boichuk, Oleksandr ; Marynchak, Oleksandra ; Kvasniuk, Viktoriia ; Protsyk, Andrii ; Miziuk, Ruslan ; Kucher, Andrii ; Simchych, Marianna ; Hryzhak, Lilia ; Kuravkin, Mariia ; Department of Airborne Infections of Communal Non-Commercial Enterprise, Ivano-Frankivsk Phthisiatry-Pulmonology Center, Ivano-Frankivsk, Ukraine ; Infectious Diseases and Epidemiology Department, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine ; Department of Therapy, Family and Emergency Medicines of Postgraduate Education, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine</creatorcontrib><description>Cardiovascular pathology can complicate the course of COVID-19. The study aimed to identify echocardiographic abnormalities and key prognostic factors influencing severe and fatal COVID-19 outcomes. This retrospective cohort study included clinical and echocardiogram data from 194 medical records of hospitalized patients with COVID-19: 100 moderate cases, 34 severe cases with favorable outcomes, and 60 severe cases with fatal outcomes. Severe patients with favorable outcomes had greater reductions in left ventricular systolic fraction of left ventricle compared to moderate cases (23.5%
. 7.0%, respectively, p=0.008) and ejection fraction of left ventricle (14.7%
. 3.0%, respectively, p=0.013), grade I diastolic dysfunction of the left ventricle (20.6%
. 8.0%, respectively, p=0.044), and pulmonary hypertension (29.41%
. 10.0%, respectively, p=0.006). Patients with fatal outcomes had a mean age of 67.1±1.51 years, chronic heart failure functional class II (58.3%), hypertension (50.0%), type 2 diabetes (43.3%), and obesity (33.3%). Compared to severe cases but with favorable outcomes, fatal cases had a greater decrease in left ventricular ejection fraction (36.7%
. 14.7%, respectively, p=0.024), various types of myocardial dysfunction (51.7%
. 29.4%, respectively, p=0.037) and a trend towards increased pulmonary hypertension (48.3%
. 29.4%, respectively, p=0.074). Consequently, chronic heart failure class II, reduced left ventricular ejection fraction, various myocardial dysfunctions, and pulmonary hypertension emerged as key cardiac risk factors for severe disease progression and mortality in patients with COVID-19.</description><identifier>ISSN: 1844-3117</identifier><identifier>ISSN: 1844-122X</identifier><identifier>EISSN: 1844-3117</identifier><identifier>DOI: 10.25122/jml-2023-0206</identifier><identifier>PMID: 38406777</identifier><language>eng</language><publisher>Romania: Carol Daila University Foundation</publisher><subject>Age ; Body mass index ; Cardiovascular disease ; Cohort analysis ; Coronaviruses ; COVID-19 ; Diabetes ; Ejection fraction ; Fatalities ; Heart attacks ; Heart failure ; Hospitalization ; Hospitals ; Infectious diseases ; Medical records ; Mortality ; Obesity ; Original ; Pathology ; Patients ; Pneumonia ; Pulmonary arteries ; Pulmonary hypertension ; Severe acute respiratory syndrome ; Ultrasonic imaging ; Viral infections</subject><ispartof>Journal of medicine and life, 2023-11, Vol.16 (11), p.1692-1700</ispartof><rights>2023 The Author(s).</rights><rights>Copyright Carol Daila University Foundation Nov 2023</rights><rights>2023 The Author(s) 2023</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2896-89629cc62d93f59ec83f617ee49dfae7b3388bddd9214e17ec6b53a6e30f02793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10893567/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10893567/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38406777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hryzhak, Ihor</creatorcontrib><creatorcontrib>Pryshliak, Oleksandra</creatorcontrib><creatorcontrib>Kobryn, Taras</creatorcontrib><creatorcontrib>Fedorov, Sergiy</creatorcontrib><creatorcontrib>Boichuk, Oleksandr</creatorcontrib><creatorcontrib>Marynchak, Oleksandra</creatorcontrib><creatorcontrib>Kvasniuk, Viktoriia</creatorcontrib><creatorcontrib>Protsyk, Andrii</creatorcontrib><creatorcontrib>Miziuk, Ruslan</creatorcontrib><creatorcontrib>Kucher, Andrii</creatorcontrib><creatorcontrib>Simchych, Marianna</creatorcontrib><creatorcontrib>Hryzhak, Lilia</creatorcontrib><creatorcontrib>Kuravkin, Mariia</creatorcontrib><creatorcontrib>Department of Airborne Infections of Communal Non-Commercial Enterprise, Ivano-Frankivsk Phthisiatry-Pulmonology Center, Ivano-Frankivsk, Ukraine</creatorcontrib><creatorcontrib>Infectious Diseases and Epidemiology Department, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine</creatorcontrib><creatorcontrib>Department of Therapy, Family and Emergency Medicines of Postgraduate Education, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine</creatorcontrib><title>Clinical and echocardiographic findings in patients with COVID-19 across different severity levels</title><title>Journal of medicine and life</title><addtitle>J Med Life</addtitle><description>Cardiovascular pathology can complicate the course of COVID-19. The study aimed to identify echocardiographic abnormalities and key prognostic factors influencing severe and fatal COVID-19 outcomes. This retrospective cohort study included clinical and echocardiogram data from 194 medical records of hospitalized patients with COVID-19: 100 moderate cases, 34 severe cases with favorable outcomes, and 60 severe cases with fatal outcomes. Severe patients with favorable outcomes had greater reductions in left ventricular systolic fraction of left ventricle compared to moderate cases (23.5%
. 7.0%, respectively, p=0.008) and ejection fraction of left ventricle (14.7%
. 3.0%, respectively, p=0.013), grade I diastolic dysfunction of the left ventricle (20.6%
. 8.0%, respectively, p=0.044), and pulmonary hypertension (29.41%
. 10.0%, respectively, p=0.006). Patients with fatal outcomes had a mean age of 67.1±1.51 years, chronic heart failure functional class II (58.3%), hypertension (50.0%), type 2 diabetes (43.3%), and obesity (33.3%). Compared to severe cases but with favorable outcomes, fatal cases had a greater decrease in left ventricular ejection fraction (36.7%
. 14.7%, respectively, p=0.024), various types of myocardial dysfunction (51.7%
. 29.4%, respectively, p=0.037) and a trend towards increased pulmonary hypertension (48.3%
. 29.4%, respectively, p=0.074). Consequently, chronic heart failure class II, reduced left ventricular ejection fraction, various myocardial dysfunctions, and pulmonary hypertension emerged as key cardiac risk factors for severe disease progression and mortality in patients with COVID-19.</description><subject>Age</subject><subject>Body mass index</subject><subject>Cardiovascular disease</subject><subject>Cohort analysis</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Diabetes</subject><subject>Ejection fraction</subject><subject>Fatalities</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Infectious diseases</subject><subject>Medical records</subject><subject>Mortality</subject><subject>Obesity</subject><subject>Original</subject><subject>Pathology</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Pulmonary arteries</subject><subject>Pulmonary hypertension</subject><subject>Severe acute respiratory syndrome</subject><subject>Ultrasonic imaging</subject><subject>Viral infections</subject><issn>1844-3117</issn><issn>1844-122X</issn><issn>1844-3117</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdUU1rGzEQFaElCWmuPQZBL71soo9daXUqxUkbQyCXtlehlUa2jKx1pbVD_n3kOAlpBYMG3pvHzHsIfabkknWUsavVOjaMMN4QRsQROqV92zacUvnhXX-CzktZkfraTgjBj9EJ71sipJSnaJjFkII1EZvkMNjlaE12YVxks1kGi31ILqRFwSHhjZkCpKnghzAt8ez-z_y6oQobm8dSsAveQ644LrCDHKZHHGsTyyf00ZtY4PzlP0O_f9z8mt02d_c_57Pvd41lvRJNLaasFcwp7jsFtudeUAnQKucNyIHzvh-cc4rRFipgxdBxI4ATT5hU_Ax9O-hutsManK2rZBP1Joe1yY96NEH_i6Sw1ItxpynpFe-ErApfXxTy-HcLZdLrUCzEaBKM26KZ4tXtaqmo1C__UVfjNqd6n-akaxklku9ZlwfWs0UZ_Ns2lOjnCHWNUO8j1PsI68DF-xve6K-B8ScZPJfW</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Hryzhak, Ihor</creator><creator>Pryshliak, Oleksandra</creator><creator>Kobryn, Taras</creator><creator>Fedorov, Sergiy</creator><creator>Boichuk, Oleksandr</creator><creator>Marynchak, Oleksandra</creator><creator>Kvasniuk, Viktoriia</creator><creator>Protsyk, Andrii</creator><creator>Miziuk, Ruslan</creator><creator>Kucher, Andrii</creator><creator>Simchych, Marianna</creator><creator>Hryzhak, Lilia</creator><creator>Kuravkin, Mariia</creator><general>Carol Daila University Foundation</general><general>Carol Davila University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20231101</creationdate><title>Clinical and echocardiographic findings in patients with COVID-19 across different severity levels</title><author>Hryzhak, Ihor ; Pryshliak, Oleksandra ; Kobryn, Taras ; Fedorov, Sergiy ; Boichuk, Oleksandr ; Marynchak, Oleksandra ; Kvasniuk, Viktoriia ; Protsyk, Andrii ; Miziuk, Ruslan ; Kucher, Andrii ; Simchych, Marianna ; Hryzhak, Lilia ; Kuravkin, Mariia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2896-89629cc62d93f59ec83f617ee49dfae7b3388bddd9214e17ec6b53a6e30f02793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age</topic><topic>Body mass index</topic><topic>Cardiovascular disease</topic><topic>Cohort analysis</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Diabetes</topic><topic>Ejection fraction</topic><topic>Fatalities</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Infectious diseases</topic><topic>Medical records</topic><topic>Mortality</topic><topic>Obesity</topic><topic>Original</topic><topic>Pathology</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Pulmonary arteries</topic><topic>Pulmonary hypertension</topic><topic>Severe acute respiratory syndrome</topic><topic>Ultrasonic imaging</topic><topic>Viral infections</topic><toplevel>online_resources</toplevel><creatorcontrib>Hryzhak, Ihor</creatorcontrib><creatorcontrib>Pryshliak, Oleksandra</creatorcontrib><creatorcontrib>Kobryn, Taras</creatorcontrib><creatorcontrib>Fedorov, Sergiy</creatorcontrib><creatorcontrib>Boichuk, Oleksandr</creatorcontrib><creatorcontrib>Marynchak, Oleksandra</creatorcontrib><creatorcontrib>Kvasniuk, Viktoriia</creatorcontrib><creatorcontrib>Protsyk, Andrii</creatorcontrib><creatorcontrib>Miziuk, Ruslan</creatorcontrib><creatorcontrib>Kucher, Andrii</creatorcontrib><creatorcontrib>Simchych, Marianna</creatorcontrib><creatorcontrib>Hryzhak, Lilia</creatorcontrib><creatorcontrib>Kuravkin, Mariia</creatorcontrib><creatorcontrib>Department of Airborne Infections of Communal Non-Commercial Enterprise, Ivano-Frankivsk Phthisiatry-Pulmonology Center, Ivano-Frankivsk, Ukraine</creatorcontrib><creatorcontrib>Infectious Diseases and Epidemiology Department, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine</creatorcontrib><creatorcontrib>Department of Therapy, Family and Emergency Medicines of Postgraduate Education, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicine and life</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hryzhak, Ihor</au><au>Pryshliak, Oleksandra</au><au>Kobryn, Taras</au><au>Fedorov, Sergiy</au><au>Boichuk, Oleksandr</au><au>Marynchak, Oleksandra</au><au>Kvasniuk, Viktoriia</au><au>Protsyk, Andrii</au><au>Miziuk, Ruslan</au><au>Kucher, Andrii</au><au>Simchych, Marianna</au><au>Hryzhak, Lilia</au><au>Kuravkin, Mariia</au><aucorp>Department of Airborne Infections of Communal Non-Commercial Enterprise, Ivano-Frankivsk Phthisiatry-Pulmonology Center, Ivano-Frankivsk, Ukraine</aucorp><aucorp>Infectious Diseases and Epidemiology Department, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine</aucorp><aucorp>Department of Therapy, Family and Emergency Medicines of Postgraduate Education, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and echocardiographic findings in patients with COVID-19 across different severity levels</atitle><jtitle>Journal of medicine and life</jtitle><addtitle>J Med Life</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>16</volume><issue>11</issue><spage>1692</spage><epage>1700</epage><pages>1692-1700</pages><issn>1844-3117</issn><issn>1844-122X</issn><eissn>1844-3117</eissn><abstract>Cardiovascular pathology can complicate the course of COVID-19. The study aimed to identify echocardiographic abnormalities and key prognostic factors influencing severe and fatal COVID-19 outcomes. This retrospective cohort study included clinical and echocardiogram data from 194 medical records of hospitalized patients with COVID-19: 100 moderate cases, 34 severe cases with favorable outcomes, and 60 severe cases with fatal outcomes. Severe patients with favorable outcomes had greater reductions in left ventricular systolic fraction of left ventricle compared to moderate cases (23.5%
. 7.0%, respectively, p=0.008) and ejection fraction of left ventricle (14.7%
. 3.0%, respectively, p=0.013), grade I diastolic dysfunction of the left ventricle (20.6%
. 8.0%, respectively, p=0.044), and pulmonary hypertension (29.41%
. 10.0%, respectively, p=0.006). Patients with fatal outcomes had a mean age of 67.1±1.51 years, chronic heart failure functional class II (58.3%), hypertension (50.0%), type 2 diabetes (43.3%), and obesity (33.3%). Compared to severe cases but with favorable outcomes, fatal cases had a greater decrease in left ventricular ejection fraction (36.7%
. 14.7%, respectively, p=0.024), various types of myocardial dysfunction (51.7%
. 29.4%, respectively, p=0.037) and a trend towards increased pulmonary hypertension (48.3%
. 29.4%, respectively, p=0.074). Consequently, chronic heart failure class II, reduced left ventricular ejection fraction, various myocardial dysfunctions, and pulmonary hypertension emerged as key cardiac risk factors for severe disease progression and mortality in patients with COVID-19.</abstract><cop>Romania</cop><pub>Carol Daila University Foundation</pub><pmid>38406777</pmid><doi>10.25122/jml-2023-0206</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1844-3117 |
| ispartof | Journal of medicine and life, 2023-11, Vol.16 (11), p.1692-1700 |
| issn | 1844-3117 1844-122X 1844-3117 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10893567 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
| subjects | Age Body mass index Cardiovascular disease Cohort analysis Coronaviruses COVID-19 Diabetes Ejection fraction Fatalities Heart attacks Heart failure Hospitalization Hospitals Infectious diseases Medical records Mortality Obesity Original Pathology Patients Pneumonia Pulmonary arteries Pulmonary hypertension Severe acute respiratory syndrome Ultrasonic imaging Viral infections |
| title | Clinical and echocardiographic findings in patients with COVID-19 across different severity levels |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T12%3A34%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20echocardiographic%20findings%20in%20patients%20with%20COVID-19%20across%20different%20severity%20levels&rft.jtitle=Journal%20of%20medicine%20and%20life&rft.au=Hryzhak,%20Ihor&rft.aucorp=Department%20of%20Airborne%20Infections%20of%20Communal%20Non-Commercial%20Enterprise,%20Ivano-Frankivsk%20Phthisiatry-Pulmonology%20Center,%20Ivano-Frankivsk,%20Ukraine&rft.date=2023-11-01&rft.volume=16&rft.issue=11&rft.spage=1692&rft.epage=1700&rft.pages=1692-1700&rft.issn=1844-3117&rft.eissn=1844-3117&rft_id=info:doi/10.25122/jml-2023-0206&rft_dat=%3Cproquest_pubme%3E3054210736%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3054210736&rft_id=info:pmid/38406777&rfr_iscdi=true |